Literature DB >> 19079156

The immune geography of IgA induction and function.

A J Macpherson1, K D McCoy, F-E Johansen, P Brandtzaeg.   

Abstract

The production of immunoglobulin A (IgA) in mammals exceeds all other isotypes, and it is mostly exported across mucous membranes. The discovery of IgA and the realization that it dominates humoral mucosal immunity, in contrast to the IgG dominance of the systemic immune system, was early evidence for the distinct nature of mucosal immunology. It is now clear that IgA can function in high-affinity modes for neutralization of toxins and pathogenic microbes, and as a low-affinity system to contain the dense commensal microbiota within the intestinal lumen. The basic map of induction of IgA B cells in the Peyer's patches, which then circulate through the lymph and bloodstream to seed the mucosa with precursors of plasma cells that produce dimeric IgA for export through the intestinal epithelium, has been known for more than 30 years. In this review, we discuss the mechanisms underlying selective IgA induction of mucosal B cells for IgA production and the immune geography of their homing characteristics. We also review the functionality of secretory IgA directed against both commensal organisms and pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079156     DOI: 10.1038/mi.2007.6

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  343 in total

Review 1.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

3.  Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues.

Authors:  Keely G McDonald; Jacquelyn S McDonough; Brian K Dieckgraefe; Rodney D Newberry
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

Review 4.  Clinical consequences of defects in B-cell development.

Authors:  Andre M Vale; Harry W Schroeder
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

Review 5.  Mucosal control of the intestinal microbial community.

Authors:  Sylvia Brugman; Edward E S Nieuwenhuis
Journal:  J Mol Med (Berl)       Date:  2010-06-04       Impact factor: 4.599

6.  The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions.

Authors:  Malin E V Johansson; Jessica M Holmén Larsson; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

7.  B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.

Authors:  Donna Kirkland; Alicia Benson; Julie Mirpuri; Reed Pifer; Baidong Hou; Anthony L DeFranco; Felix Yarovinsky
Journal:  Immunity       Date:  2012-02-01       Impact factor: 31.745

Review 8.  Transepithelial antigen delivery in the small intestine: different paths, different outcomes.

Authors:  Kathryn A Knoop; Mark J Miller; Rodney D Newberry
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

Review 9.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

10.  Lymphotoxin alpha-deficient mice clear persistent rotavirus infection after local generation of mucosal IgA.

Authors:  Uri Lopatin; Sarah E Blutt; Margaret E Conner; Brian L Kelsall
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.